Regenerative Medicine and Stem Cells Technologies

Growing human organs inside other animals has taken another step away from science-fiction, with researchers announcing they have grown sheep embryos containing human cells.

While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains to control fluid pressure in the eye.

Creating new healthy heart muscle cells within a patients own ailing heart. This is how scientists hope to reverse heart disease one day. Today, a new study led by UNC-Chapel Hill researchers reveals key molecular details that should be useful in developing this ambitious approach.

In the global race to use human immune cells to fight cancers, a little-known Chinese firm called GenScript Biotech Corp. is emerging as one of the biggest stock gainers.

"Take a knee." "On bended knee." A "knee-slapper." "The bees knees." The knee certainly carries a lot of weight in the English language, just as it does in the body. As the largest and one of the most complicated joints, the knee is also one of the most easily injured. Anatomically, its no wonder – the knee connects the two longest levers in the body: the thigh and lower leg.

Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering these therapies to patients worldwide.

Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published today in the New England Journal of Medicine.

The Report named “Global Animal Stem Cell Therapy Market” serves crucial perceptions into global Animal Stem Cell Therapy industry along with newfangled industry details, currently dominating players in Animal Stem Cell Therapy, chapter wise analysis of each section and looming industry trends, which will guide the readers to target Animal Stem Cell Therapy market product Specifications and clients driving the long-term market revenue and profitability.

Scientists at Washington University School of Medicine in St. Louis have transformed skin cells from patients with Huntington’s disease into the type of brain cell affected by the disorder.

To more accurately mimic these features, researchers have developed models of liver tumors called patient-derived xenografts (PDX). Although these models provide a truer picture of how effective potential cancer drugs would be in humans, they are also expensive and time-consuming to create